Probiotic strain Nissle 1917 outcompetes intestinalpathogens during biofilm formation Free

Abstract

Many bacterial infections are associated with biofilm formation. Bacterialbiofilms can develop on essentially all kinds of surfaces, producing chronicand often intractable infections. is an importantpathogen causing a wide range of gastrointestinal infections. strain Nissle 1917 has been used for many decades as a probiotic againsta variety of intestinal disorders and is probably the best field-tested strain in the world. Here we have investigated the biofilm-formingcapacity of Nissle 1917. We found that the strain was a good biofilm former.Not only was it significantly better at biofilm formation than enteropathogenic,enterotoxigenic and enterohaemorrhagic strains, it was alsoable to outcompete such strains during biofilm formation. The results supportthe notion of bacterial prophylaxis employing Nissle 1917 and may partiallyexplain why the strain has a beneficial effect on many intestinal disorders.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.008672-0
2010-04-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/59/4/392.html?itemId=/content/journal/jmm/10.1099/jmm.0.008672-0&mimeType=html&fmt=ahah

References

  1. Anderson G. G., Palermo J. J., Schilling J. D., Roth R., Heuser J., Hultgren S. J. 2003; Intracellularbacterial biofilm-like pods in urinary tract infections. Science 301:105–107 [CrossRef]
    [Google Scholar]
  2. Blum G., Marre R., Hacker J. 1995; Properties of Escherichia coli strains of serotype O6. Infection 23:234–236 [CrossRef]
    [Google Scholar]
  3. Brady R. A., Leid J. G., Calhoun J. H., Costerton J. W., Shirtliff M. E. 2008; Osteomyelitis and the roleof biofilms in chronic infection. FEMS Immunol Med Microbiol 52:13–22 [CrossRef]
    [Google Scholar]
  4. Christensen B. B., Sternberg C., Andersen J. B., Palmer R. J. Jr, Nielsen A. T., Givskov M., Molin S. 1999; Molecular tools for study of biofilm physiology. Methods Enzymol 310:20–42
    [Google Scholar]
  5. Clark D. J., Maaloe O. 1967).DNA; replication and the division cycle in Escherichia coli . J Mol Biol 23:99–112 [CrossRef]
    [Google Scholar]
  6. Costerton J. W., Lewandowski Z., Caldwell D. E., Korber D. R., Lappin-Scott H. M. 1995; Microbialbiofilms. Annu Rev Microbiol 49:711–745 [CrossRef]
    [Google Scholar]
  7. Costerton J. W., Stewart P. S., Greenberg E. P. 1999; Bacterial biofilms: a common cause of persistentinfections. Science 284:1318–1322 [CrossRef]
    [Google Scholar]
  8. Costerton W., Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G. 2003; The application of biofilm scienceto the study and control of chronic bacterial infections. J ClinInvest 112:1466–1477
    [Google Scholar]
  9. Cremonini F., Di Caro S., Nista E. C., Bartolozzi F., Capelli G., Gasbarrini G., Gasbarrini A. 2002; Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 16:1461–1467 [CrossRef]
    [Google Scholar]
  10. Da Re S., Ghigo J.-M. 2006).A; CsgD-independent pathway for cellulose production and biofilm formationof Escherichia coli . J Bacteriol 188:3073–3087 [CrossRef]
    [Google Scholar]
  11. Darouiche R. O., Thornby J. I., Cerra-Stewart C., Donovan W. H., Hull R. A. 2005; Bacterial interferencefor prevention of urinary tract infection: a prospective, randomized, placebo-controlled,double-blind pilot trial. Clin Infect Dis 41:1531–1534 [CrossRef]
    [Google Scholar]
  12. Ebel F., Deibel C., Kresse A., Guzman C., Chakraborty T. 1996; Temperature- and medium-dependent secretionof proteins by Shiga toxin-producing Escherichia coli . Infect Immun 64:4472–4479
    [Google Scholar]
  13. Evans D. G., Silver R. P., Evans D. J., Chase D. G., Gorbach S. L. 1975; Plasmid-controlled colonizationfactor associated with virulence in Escherichia coli enterotoxigenicfor humans. Infect Immun 12:656–667
    [Google Scholar]
  14. Ferrières L., Hancock V., Klemm P. 2007a; Biofilm exclusion of uropathogenic bacteria by selectedasymptomatic bacteriuria Escherichia coli strains. Microbiology 153:1711–1719 [CrossRef]
    [Google Scholar]
  15. Ferrières L., Hancock V., Klemm P. 2007b; Specific selection for virulent urinary tract infectious Escherichia coli strains during catheter-associated biofilm formation. FEMS Immunol Med Microbiol 51:212–219 [CrossRef]
    [Google Scholar]
  16. Grozdanov L., Raasch C., Schulze J., Sonnenborn U., Gottschalk G., Hacker J., Dobrindt U. 2004; Analysisof the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J Bacteriol 186:5432–5441 [CrossRef]
    [Google Scholar]
  17. Hancock V., Ferrières L., Klemm P. 2007; Biofilm formation by asymptomatic and virulent urinary tractinfectious Escherichia coli strains. FEMS Microbiol Lett 267:30–37 [CrossRef]
    [Google Scholar]
  18. Hancock V., Ferrières L., Klemm P. 2008a; The ferric yersiniabactin uptake receptor FyuA is requiredfor efficient biofilm formation by urinary tract infectious Escherichiacoli in human urine. Microbiology 154:167–175 [CrossRef]
    [Google Scholar]
  19. Hancock V., Seshasayee A. S., Ussery D. W., Luscombe N.M., Klemm P. 2008b; Transcriptomics and adaptivegenomics of the asymptomatic bacteriuria Escherichia coli strain83972. Mol Genet Genomics 279:523–534 [CrossRef]
    [Google Scholar]
  20. Kjaergaard K, Schembri M. A., Ramos C, Molin S, Klemm P. 2000; Antigen 43 facilitates formationof multispecies biofilms. Environ Microbiol 2:695–702 [CrossRef]
    [Google Scholar]
  21. Krogfelt K. A., Poulsen L. K., Molin S. 1993; Identification of coccoid Escherichia coli BJ4cells in the large intestine of streptomycin-treated mice. InfectImmun 61:5029–5034
    [Google Scholar]
  22. Lasaro M. A., Salinger N., Zhang J., Wang Y., Zhong Z., Goulian M., Zhu J. 2009; F1C fimbriae playan important role in biofilm formation and intestinal colonization by the Escherichia coli commensal strain Nissle 1917. Appl EnvironMicrobiol 75:246–251
    [Google Scholar]
  23. Lodinova-Zadnikova R., Sonnenborn U. 1997; Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbialpathogens in newborn infants. Biol Neonate 71:224–232 [CrossRef]
    [Google Scholar]
  24. Lodinova-Zadnikova R., Bartakova Z., Tlaskalova H. 1992; The effect of oral colonization by non-pathogenic E. coli on the immune response in neonates and possibilities of its usein the prevention of nosocomial infections in children at risk. Cesk Epidemiol Mikrobiol Imunol 42:126–132
    [Google Scholar]
  25. Macfarlane S., Dillon J. F. 2007; Microbial biofilms in the human gastrointestinal tract. JAppl Microbiol 102:1187–1196
    [Google Scholar]
  26. Parsek M. R., Singh P. K. 2003; Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 57:677–701 [CrossRef]
    [Google Scholar]
  27. Patzer S. I., Baquero M. R., Bravo D., Moreno F., Hantke K. 2003; The colicin G, H and X determinants encodemicrocins M and H47, which might utilize the catecholate siderophore receptorsFepA, Cir, Fiu and IroN. Microbiology 149:2557–2570 [CrossRef]
    [Google Scholar]
  28. Pratt L. A., Kolter R. 1998).Genetic; analysis of Escherichia coli biofilm formation: roles offlagella, motility, chemotaxis and type I pili. Mol Microbiol 30:285–293 [CrossRef]
    [Google Scholar]
  29. Prigent-Combaret C., Prensier G., Le Thi T. T., Vidal O., Lejeune P., Dorel C. 2000; Developmentalpathway for biofilm formation in curli-producing Escherichia coli strains: role of flagella, curli and colanic acid. Environ Microbiol 2:450–464 [CrossRef]
    [Google Scholar]
  30. Reid G., Denstedt J. D., Kang Y. S., Lam D., Nause C. 1992; Microbial adhesion and biofilm formationon ureteral stents in vitro and in vivo. J Urol 148:1592–1594
    [Google Scholar]
  31. Reid G., Howard J., Gan B. S. 2001; Can bacterial interference prevent infection?. Trends Microbiol 9:424–428 [CrossRef]
    [Google Scholar]
  32. Schultz M., Strauch U. G., Linde H.-J., Watzl S., Obermeier F., Gottl C., Dunger N., Grunwald N., Scholmerich J., Rath H. C. 2004; Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in twodifferent murine models of colitis. Clin Diagn Lab Immunol 11:372–378
    [Google Scholar]
  33. Schulze J., Sonnenborn U. 1995; Oral administration of a certain strain of live Escherichia coli for intestinal disorders?. Infection 23:184–188 [CrossRef]
    [Google Scholar]
  34. Sonnenborn U., Schulze J. 1997; Actual clinical studies on the efficacy of a probiotic drug. Microecol Ther 26:211–220
    [Google Scholar]
  35. Sundén F, Håkansson L, Ljunggren E, Wullt B. 2006; Bacterial interference – isdeliberate colonization with Escherichia coli 83972 an alternativetreatment for patients with recurrent urinary tract infection?. Int J Antimicrob Agents 28:S26–S29 [CrossRef]
    [Google Scholar]
  36. Wadolkowski E. A., Laux D. C., Cohen P. S. 1988; Colonization of the streptomycin-treated mouse large intestineby a human fecal Escherichia coli strain: role of adhesion to mucosalreceptors. Infect Immun 56:1036–1043
    [Google Scholar]
  37. Warren J. W. 2001; Catheter-associatedurinary tract infections. Int J Antimicrob Agents 17:299–303 [CrossRef]
    [Google Scholar]
  38. Wieler L. H., Tigges M., Ebel F., Schäferkordt S., Djafari S., Schlapp T., Baljer G., Chakraborty T. 1996; The enterohemolysin phenotype of bovine Shiga-like toxin-producing Escherichia coli (SLTEC) is encoded by the EHEC-hemolysin gene. Vet Microbiol 52:153–164 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.008672-0
Loading
/content/journal/jmm/10.1099/jmm.0.008672-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed